Geoffrey Parker

Geoffrey Parker is a highly accomplished professional with a strong background in finance and operations management.

He holds an A.B. Double Major in Economics and Engineering Sciences from Dartmouth College and a Master of Business Administration (MBA) from Stanford University Graduate School of Business.

With a vast array of experiences, Geoffrey has held key executive positions in several prominent organizations, including Allogene Therapeutics, Tricida, Inc., and Anacor Pharmaceuticals, Inc.

His expertise extends to serving on the boards of various companies, such as Better Therapeutics, Perrigo Company plc, Genomic Health, and Sunesis Pharmaceuticals, Inc., among others.

Prior to his executive roles, Geoffrey Parker has a solid foundation in finance, having worked at prestigious institutions like Goldman, Sachs & Co. in various capacities, including Managing Director and Vice President.

His educational background, coupled with his extensive professional experience, has equipped Geoffrey with a diverse skill set and a deep understanding of the financial and healthcare sectors.

Geoffrey Parker's contributions to the organizations he has been a part of highlight his strategic vision and leadership capabilities, making him a respected figure in the industry.